These large and stable companies offer strong long-term opportunities heading into 2025.

Johnson & Johnson's robust pharmaceutical division drives growth amidst competitive challenges. Strategic divestitures and acquisitions shape JNJ's market presence and future prospects.

A California motorsports park where a 9-year-old girl died in a “freak accident” crash earlier this year has permanently closed as a legal flight plays over her death. Pint-sized star Brooke ...

Johnson & Johnson (J&J), formed in 1886, is a prominent American multinational corporation known for medical devices, pharmaceuticals, and consumer packaged goods. The company distinguishes itself ...

Current price $155.04 52-week high $168.85 ...

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our P/B Growth Investor model based on the published strategy ...

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our P/B Growth Investor model based on the published strategy ...

Some 35+ years ago, David Wilson, currently group vice president and president of TRD USA, was a considerable expert of ...

Jimmie Johnson Opens up About Cycling Moment With Dale Jr., sharing their humorous friendship and fitness journey beyond ...